group VI iPLA₂ Antibodies

Santa Cruz Biotechnology features a diverse variety of group VI iPLA₂ monoclonal antibodies for various research applications. group VI iPLA₂ Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Group VI iPLA₂ enzymes play a crucial role in the hydrolysis of phospholipids, leading to the release of fatty acids and lysolipids, which are important for cell signaling and membrane dynamics. The involvement of group VI iPLA₂ in inflammatory processes and cellular responses makes it significant in various physiological and pathological conditions. Understanding group VI iPLA₂ function is essential for advancing research in areas such as cancer, neurodegenerative diseases, and cardiovascular disorders. Group VI iPLA₂ research has revealed important insights into lipid metabolism and cellular homeostasis. Investigating group VI iPLA₂ expression patterns helps illuminate its role in different tissue types and disease states. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to make meaningful contributions to understanding cellular processes and disease mechanisms.